These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2655207)

  • 1. Further observations on the patterns of clearance of incompatible red cells.
    Mollison PL
    Transfusion; 1989 May; 29(4):347-54. PubMed ID: 2655207
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival curves of incompatible red cells. An analytical review.
    Mollison PL
    Transfusion; 1986; 26(1):43-50. PubMed ID: 3511574
    [No Abstract]   [Full Text] [Related]  

  • 3. Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion.
    Fata CR; Gehrie EA; Young PP
    Transfusion; 2015 Jul; 55(7):1823-4. PubMed ID: 26172150
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival of Kn(a+) McC(a+) red cells in a patient with anti- "Kna/McCa".
    Ballas SK; Viggiano E; Draper EK
    Transfusion; 1984; 24(1):22-4. PubMed ID: 6695436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of homozygous Coa (Colton) red cells in a patient with anti-Coa.
    Kurtz SR; Kuszaj T; Ouellet R; Valeri CR
    Vox Sang; 1982 Jul; 43(1):28-30. PubMed ID: 7113116
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term 51Cr survival of serologically incompatible red cell units.
    Davey RJ
    Transfusion; 1985; 25(6):589-90. PubMed ID: 4071607
    [No Abstract]   [Full Text] [Related]  

  • 7. Removal of ABO-incompatible red cells from lymphocytapheresis and granulocytapheresis components before transfusion.
    Wuest DL; Reich LM
    Transfusion; 1997 Feb; 37(2):144-9. PubMed ID: 9051088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double buffy coat method for red cell removal from ABO-incompatible marrow.
    Rosenfeld CS; Tedrow H; Boegel F; Gremba C; Shadduck RK
    Transfusion; 1989 Jun; 29(5):415-7. PubMed ID: 2660336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term in vivo survival of Rh(D)-negative donor red cells in a patient with anti-LW.
    Chaplin H; Hunter VL; Rosche ME; Shirey RS
    Transfusion; 1985; 25(1):39-43. PubMed ID: 3918363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortened long-term survival of incompatible red cells in a patient with anti-McCoy-like antibody. Immunoglobulin characteristics of this antibody.
    Gandhi JG; Moulds JJ; Szymanski IO
    Transfusion; 1984; 24(1):16-8. PubMed ID: 6695434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
    Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed intravascular haemolysis following multiple asymptomatic ABO-incompatible red blood cell transfusions in a patient with hepatic failure.
    Tormey CA; Stack G
    Vox Sang; 2008 Oct; 95(3):232-5. PubMed ID: 19121188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units.
    Baldwin ML; Ness PM; Barrasso C; Kickler TS; Drew H; Tsan MF; Shirey RS
    Transfusion; 1985; 25(1):34-8. PubMed ID: 3969699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of storage time of human red cells on intestinal microcirculatory oxygenation in a rat isovolemic exchange model.
    Raat NJ; Verhoeven AJ; Mik EG; Gouwerok CW; Verhaar R; Goedhart PT; de Korte D; Ince C
    Crit Care Med; 2005 Jan; 33(1):39-45; discussion 238-9. PubMed ID: 15644646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fibronectin: a third opsonic protein involved in immune clearance and destruction of erythrocytes after infusion of incompatible blood.
    Hathaway TK; Adams JL
    Transplant Proc; 1988 Dec; 20(6):1096-102. PubMed ID: 3144069
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
    Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion.
    Liepkalns JS; Cadwell CM; Stowell SR; Hod EA; Spitalnik SL; Zimring JC
    Transfusion; 2013 Jun; 53(6):1319-27. PubMed ID: 23033973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival studies of 51Cr Ch(a+) red blood cells in a patient with anti-Cha, and massive transfusion of incompatible blood.
    Nordhagen R; Aas M
    Vox Sang; 1979; 37(3):179-81. PubMed ID: 494587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion of incompatible blood in rhesus monkeys and baboons.
    Socha WW; Rowe AW; Lenny LL; Lasano SG; Moor-Jankowski J
    Lab Anim Sci; 1982 Feb; 32(1):48-56. PubMed ID: 7078073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion reaction caused by anti-Vr, the first case reported.
    Boonen K; van der Stokker A; Folman C; van de Kerkhof D
    Transfus Med; 2013 Jun; 23(3):204-5. PubMed ID: 23581842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.